Found: 14
Select item for more details and to access through your institution.
Blocking interaction between SHP2 and PD‐1 denotes a novel opportunity for developing PD‐1 inhibitors.
- Published in:
- EMBO Molecular Medicine, 2020, v. 12, n. 6, p. 1, doi. 10.15252/emmm.201911571
- By:
- Publication type:
- Article
Cellular mechanisms and treatments for chemobrain: insight from aging and neurodegenerative diseases.
- Published in:
- EMBO Molecular Medicine, 2020, v. 12, n. 6, p. 1, doi. 10.15252/emmm.202012075
- By:
- Publication type:
- Article
Cystatin B is essential for proliferation and interneuron migration in individuals with EPM1 epilepsy.
- Published in:
- EMBO Molecular Medicine, 2020, v. 12, n. 6, p. 1, doi. 10.15252/emmm.201911419
- By:
- Publication type:
- Article
HDAC1 dysregulation induces aberrant cell cycle and DNA damage in progress of TDP‐43 proteinopathies.
- Published in:
- EMBO Molecular Medicine, 2020, v. 12, n. 6, p. 1, doi. 10.15252/emmm.201910622
- By:
- Publication type:
- Article
A high‐affinity, bivalent PDZ domain inhibitor complexes PICK1 to alleviate neuropathic pain.
- Published in:
- EMBO Molecular Medicine, 2020, v. 12, n. 6, p. 1, doi. 10.15252/emmm.201911248
- By:
- Publication type:
- Article
Is BCG vaccination causally related to reduced COVID‐19 mortality?
- Published in:
- EMBO Molecular Medicine, 2020, v. 12, n. 6, p. 1, doi. 10.15252/emmm.202012661
- By:
- Publication type:
- Article
'All In': a pragmatic framework for COVID‐19 testing and action on a global scale.
- Published in:
- EMBO Molecular Medicine, 2020, v. 12, n. 6, p. 1, doi. 10.15252/emmm.202012634
- By:
- Publication type:
- Article
The prospects for the SARS‐CoV‐2 pandemic in Africa.
- Published in:
- EMBO Molecular Medicine, 2020, v. 12, n. 6, p. 1, doi. 10.15252/emmm.202012488
- By:
- Publication type:
- Article
COVID‐19: lambda interferon against viral load and hyperinflammation.
- Published in:
- EMBO Molecular Medicine, 2020, v. 12, n. 6, p. 1, doi. 10.15252/emmm.202012465
- By:
- Publication type:
- Article
A new Tie1 targeted antibody blocks tumor cell extravasation and metastasis.
- Published in:
- EMBO Molecular Medicine, 2020, v. 12, n. 6, p. 1, doi. 10.15252/emmm.202012355
- By:
- Publication type:
- Article
Preclinical validation of a novel metastasis‐inhibiting Tie1 function‐blocking antibody.
- Published in:
- EMBO Molecular Medicine, 2020, v. 12, n. 6, p. 1, doi. 10.15252/emmm.201911164
- By:
- Publication type:
- Article
Tumors defective in homologous recombination rely on oxidative metabolism: relevance to treatments with PARP inhibitors.
- Published in:
- EMBO Molecular Medicine, 2020, v. 12, n. 6, p. 1, doi. 10.15252/emmm.201911217
- By:
- Publication type:
- Article
MECP2 mutations affect ciliogenesis: a novel perspective for Rett syndrome and related disorders.
- Published in:
- EMBO Molecular Medicine, 2020, v. 12, n. 6, p. 1, doi. 10.15252/emmm.201910270
- By:
- Publication type:
- Article
RIPK1‐mediated immunogenic cell death promotes anti‐tumour immunity against soft‐tissue sarcoma.
- Published in:
- EMBO Molecular Medicine, 2020, v. 12, n. 6, p. 1, doi. 10.15252/emmm.201910979
- By:
- Publication type:
- Article